{"id":186878,"date":"2026-03-06T07:00:08","date_gmt":"2026-03-06T07:00:08","guid":{"rendered":"https:\/\/www.europesays.com\/fi\/186878\/"},"modified":"2026-03-06T07:00:08","modified_gmt":"2026-03-06T07:00:08","slug":"japanissa-mullistavia-tuloksia-parkinsonin-taudin-hoidossa-uutisia-lyhyesti","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/fi\/186878\/","title":{"rendered":"Japanissa mullistavia tuloksia Parkinsonin taudin hoidossa | Uutisia lyhyesti"},"content":{"rendered":"<p class=\"aw-1gybjub aw-1p7kakr kEtdKx cEmitX yle__article__paragraph\">Japani on hyv\u00e4ksynyt kantasoluhoidon Parkinsonin tautiin ensimm\u00e4isen\u00e4 maailmassa.<\/p>\n<p class=\"aw-1gybjub aw-1p7kakr kEtdKx cEmitX yle__article__paragraph\">Menetelm\u00e4ll\u00e4 on japanilaismedian mukaan saatu hyvi\u00e4 tuloksia my\u00f6s syd\u00e4nkohtauksien hoidossa.<\/p>\n<p class=\"aw-1gybjub aw-1p7kakr kEtdKx cEmitX yle__article__paragraph\">Sumitomo Pharma -yhti\u00f6 sai valmistus- ja myyntiluvan Amchepry-hoidolle, jossa siirret\u00e4\u00e4n kantasoluja potilaan aivoihin.<\/p>\n<p class=\"aw-1gybjub aw-1p7kakr kEtdKx cEmitX yle__article__paragraph\">Japanin terveysministeri\u00f6 n\u00e4ytti vihre\u00e4\u00e4 valoa my\u00f6s uudelle syd\u00e4nsairauksien hoitomenetelm\u00e4lle.<\/p>\n<p class=\"aw-1gybjub aw-1p7kakr kEtdKx cEmitX yle__article__paragraph\">Hoidot voisivat tulla markkinoille kes\u00e4ll\u00e4. Kyseess\u00e4 olisi ensimm\u00e4inen kerta, kun kantasoluja hy\u00f6dynnet\u00e4\u00e4n kaupalliseen k\u00e4ytt\u00f6\u00f6n.<\/p>\n<p class=\"aw-1gybjub aw-1p7kakr kEtdKx cEmitX yle__article__paragraph\">AFP<\/p>\n","protected":false},"excerpt":{"rendered":"Japani on hyv\u00e4ksynyt kantasoluhoidon Parkinsonin tautiin ensimm\u00e4isen\u00e4 maailmassa. Menetelm\u00e4ll\u00e4 on japanilaismedian mukaan saatu hyvi\u00e4 tuloksia my\u00f6s syd\u00e4nkohtauksien hoidossa.&hellip;\n","protected":false},"author":2,"featured_media":74,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_share_on_mastodon":"0"},"categories":[14],"tags":[22,23,26,27,33,31,30,17,29501,24,25,28,29,15,18,21,13640,32,167,19,20,56,16,59,60,61],"class_list":["post-186878","post","type-post","status-publish","format-standard","has-post-thumbnail","category-ulkomaat","tag-breaking-news","tag-breakingnews","tag-featured-news","tag-featurednews","tag-fi","tag-finland","tag-finnish","tag-headlines","tag-kantasolut","tag-latest-news","tag-latestnews","tag-main-news","tag-mainnews","tag-news","tag-otsikot","tag-paauutiset","tag-parkinsonin-tauti","tag-suomi","tag-terveys","tag-top-stories","tag-topstories","tag-ulkomaat","tag-uutiset","tag-world","tag-world-news","tag-worldnews"],"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@fi\/116180944419108841","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/fi\/wp-json\/wp\/v2\/posts\/186878","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/fi\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/fi\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/fi\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/fi\/wp-json\/wp\/v2\/comments?post=186878"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/fi\/wp-json\/wp\/v2\/posts\/186878\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/fi\/wp-json\/wp\/v2\/media\/74"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/fi\/wp-json\/wp\/v2\/media?parent=186878"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/fi\/wp-json\/wp\/v2\/categories?post=186878"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/fi\/wp-json\/wp\/v2\/tags?post=186878"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}